DGIdb - KCNJ11 Gene Record

KCNJ11 3767 Druggable Genome

Alternate Names:

3767
POTASSIUM VOLTAGE-GATED CHANNEL SUBFAMILY J MEMBER 11
KCNJ11
BIR
HHF2
IKATP
KIR6.2
MODY13
PHHI
TNDM3
600937
6257
ENSG00000187486
OTTHUMG00000165914
Q14654
IRK11_HUMAN
POTASSIUM INWARDLY-RECTIFYING CHANNEL, SUBFAMILY J, MEMBER 11 (KCNJ11), MRNA [SOURCE:REFSEQ_DNA;ACC:NM_000525]
NM_000525.3
PA217
Inward rectifier K(+) channel Kir6.2
ATP-sensitive inward rectifier potassium channel 11
Potassium channel, inwardly rectifying subfamily J member 11
potassium inwardly rectifying channel subfamily J member 11
PNDM2

Gene Info:

Transmembrane Helix Count	2
Target Subclass	Channels
Target Main Class	Transporters
Target Subclass	InwardlyRectifyingKchannel
Target Subclass	Voltage_gated_ion_channels
Human Readable Name	DRUGGABLE GENOME
Initial Gene Query	Kir6.2
Counted Citations from 1950-2000	1209
Target Class	Transporters
Target Subclass	TC:1.A.2.1
Gene Biotype	PROTEIN_CODING

(7 More Sources)

Gene Categories: Category Details

ION CHANNEL
DRUGGABLE GENOME

Publications:

Li Q et al., 2014, KCNJ11 E23K variant is associated with the therapeutic effect of sulphonylureas in Chinese type 2 diabetic patients., Clin Exp Pharmacol Physiol
Klen J et al., 2014, CYP2C9, KCNJ11 and ABCC8 polymorphisms and the response to sulphonylurea treatment in type 2 diabetes patients., Eur J Clin Pharmacol
Javorsky M et al., 2012, KCNJ11 gene E23K variant and therapeutic response to sulfonylureas., Eur J Intern Med
Sesti G et al., 2006, The E23K variant of KCNJ11 encoding the pancreatic beta-cell adenosine 5'-triphosphate-sensitive potassium channel subunit Kir6.2 is associated with an increased risk of secondary failure to sulfonylurea in patients with type 2 diabetes., J Clin Endocrinol Metab
Gloyn AL et al., 2001, Association studies of variants in promoter and coding regions of beta-cell ATP-sensitive K-channel genes SUR1 and Kir6.2 with Type 2 diabetes mellitus (UKPDS 53)., Diabet Med
Yildiz, 2007, Vasodilating mechanisms of levosimendan: involvement of K+ channels., J. Pharmacol. Sci.
Jabůrek et al., 1998, State-dependent inhibition of the mitochondrial KATP channel by glyburide and 5-hydroxydecanoate., J. Biol. Chem.
Darendeliler F et al., 2002, ABCC8 (SUR1) and KCNJ11 (KIR6.2) mutations in persistent hyperinsulinemic hypoglycemia of infancy and evaluation of different therapeutic measures., J Pediatr Endocrinol Metab
Pearson ER et al., 2006, Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations., N Engl J Med
Ohkubo K et al., 2005, Genotypes of the pancreatic beta-cell K-ATP channel and clinical phenotypes of Japanese patients with persistent hyperinsulinaemic hypoglycaemia of infancy., Clin Endocrinol (Oxf)
de Lonlay et al., 2002, Heterogeneity of persistent hyperinsulinaemic hypoglycaemia. A series of 175 cases., Eur. J. Pediatr.
Russ et al., 2003, Binding and effect of K ATP channel openers in the absence of Mg2+., Br. J. Pharmacol.
Shindo et al., 2000, MCC-134, a novel vascular relaxing agent, is an inverse agonist for the pancreatic-type ATP-sensitive K(+) channel., J. Pharmacol. Exp. Ther.
Sakura et al., 1999, Altered functional properties of KATP channel conferred by a novel splice variant of SUR1., J. Physiol. (Lond.)
D'hahan et al., 1999, Pharmacological plasticity of cardiac ATP-sensitive potassium channels toward diazoxide revealed by ADP., Proc. Natl. Acad. Sci. U.S.A.
Lawrence et al., 2002, Effect of metabolic inhibition on glimepiride block of native and cloned cardiac sarcolemmal K(ATP) channels., Br. J. Pharmacol.
Song et al., 2001, Glimepiride block of cloned beta-cell, cardiac and smooth muscle K(ATP) channels., Br. J. Pharmacol.
Bataille, 2002, [Molecular mechanisms of insulin secretion]., Diabetes Metab.
Tsutsumi et al., 2000, Blockade of adenosine triphosphate-sensitive potassium channels by thiamylal in rat ventricular myocytes., Anesthesiology
Eguchi et al., 2005, [Effects of propofol and thiamylal on nicorandil induced ATP-sensitive potassium channel activities in cultured rat aortic smooth muscle cells]., Masui
Kawano et al., 2004, Molecular mechanisms of the inhibitory effects of propofol and thiamylal on sarcolemmal adenosine triphosphate-sensitive potassium channels., Anesthesiology
Yu M et al., 2010, KCNJ11 Lys23Glu and TCF7L2 rs290487(C/T) polymorphisms affect therapeutic efficacy of repaglinide in Chinese patients with type 2 diabetes., Clin Pharmacol Ther
Li et al., 2000, [Effects of glibenclamide on mRNA level of ATP-sensitive potassium channels of heart in normal and streptozotocin-induced diabetic rats]., Zhonghua Yi Xue Za Zhi
Jin et al., 2007, Uncoupling by (--)-epigallocatechin-3-gallate of ATP-sensitive potassium channels from phosphatidylinositol polyphosphates and ATP., Pharmacol. Res.
Proks et al., 1997, Phentolamine block of KATP channels is mediated by Kir6.2., Proc. Natl. Acad. Sci. U.S.A.
Bian X et al., 2006, Synthesis and antihyperglycemic evaluation of various protoberberine derivatives., Bioorg Med Chem Lett
Yunoki et al., 2001, The effects of flecainide on ATP-sensitive K(+) channels in pig urethral myocytes., Br. J. Pharmacol.
Tavira B et al., 2012, Association between a common KCNJ11 polymorphism (rs5219) and new-onset posttransplant diabetes in patients treated with Tacrolimus., Mol Genet Metab

GLIMEPIRIDE KCNJ11

Interaction Score: 3.59

Interaction Types & Directionality:

blocker (inhibitory)

inhibitor (inhibitory)

Interaction Info:

Mechanism of Interaction Sulfonylurea receptor 1, Kir6.2 blocker

Direct Interaction yes

Trial Name glimepiride,Amaryl

PMIDs:
25115353 24442125 22385882 16595597 11318841 12086984 11325810 12703060

Sources:
TdgClinicalTrial ChemblInteractions NCI TEND PharmGKB
THIAMYLAL KCNJ11

Interaction Score: 2.76

Interaction Types & Directionality:

inhibitor (inhibitory)

Interaction Info:

Trial Name -

Novel drug target Established target

PMIDs:
10754636 15852621 14739809

Sources:
TdgClinicalTrial TEND
GLIQUIDONE KCNJ11

Interaction Score: 2.52

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
16359864 25115353 24442125 22385882 16595597 11318841

Sources:
DTC PharmGKB
GLICLAZIDE KCNJ11

Interaction Score: 2.21

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
24442125 16595597 11318841 22385882 25115353

Sources:
PharmGKB
LEVOSIMENDAN KCNJ11

Interaction Score: 2.21

Interaction Types & Directionality:

inducer (activating)

Interaction Info:

Trial Name Levosimendan

Novel drug target Established target

PMIDs:
17452812

Sources:
TdgClinicalTrial
GLIPIZIDE KCNJ11

Interaction Score: 2.21

Interaction Types & Directionality:

blocker (inhibitory)

Interaction Info:

Mechanism of Interaction Sulfonylurea receptor 1, Kir6.2 blocker

Direct Interaction yes

PMIDs:
25115353 24442125 22385882 16595597 11318841

Sources:
ChemblInteractions PharmGKB
DIAZOXIDE KCNJ11

Interaction Score: 1.7

Interaction Types & Directionality:

inducer (activating)

Interaction Info:

Mechanism of Interaction Potassium channel, inwardly rectifying, subfamily J, member 11 opener

Direct Interaction yes

PMIDs:
12199344 16885550 15807877 11808879 12770942 10604939 10581306 10518593

Sources:
ChemblInteractions PharmGKB
GLYBURIDE KCNJ11

Interaction Score: 1.47

Interaction Types & Directionality:

blocker (inhibitory)

inhibitor (inhibitory)

Interaction Info:

Novel drug target Established target

Trial Name -

Mechanism of Interaction Sulfonylurea receptor 1, Kir6.2 blocker

PMIDs:
25115353 24442125 22385882 16595597 11318841 9593694

Sources:
TdgClinicalTrial ChemblInteractions TEND PharmGKB
BERBERRUBINE KCNJ11

Interaction Score: 1.1

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
16359864

Sources:
DTC
TOLBUTAMIDE SODIUM, STERILE KCNJ11

Interaction Score: 1.1

Interaction Types & Directionality:

blocker (inhibitory)

Interaction Info:

Mechanism of Interaction Sulfonylurea receptor 1, Kir6.2 blocker

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions
FLECAINIDE KCNJ11

Interaction Score: 0.88

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
11429398

Sources:
NCI
ACETOHEXAMIDE KCNJ11

Interaction Score: 0.74

Interaction Types & Directionality:

blocker (inhibitory)

Interaction Info:

Mechanism of Interaction Sulfonylurea receptor 1, Kir6.2 blocker

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions
MITIGLINIDE KCNJ11

Interaction Score: 0.74

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
None found

Sources:
TEND
REPAGLINIDE KCNJ11

Interaction Score: 0.59

Interaction Types & Directionality:

blocker (inhibitory)

Interaction Info:

Mechanism of Interaction Sulfonylurea receptor 1, Kir6.2 blocker

Direct Interaction yes

PMIDs:
20054294

Sources:
ChemblInteractions TEND PharmGKB
BERBERINE CHLORIDE KCNJ11

Interaction Score: 0.55

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
16359864

Sources:
DTC
SARAKALIM KCNJ11

Interaction Score: 0.55

Interaction Types & Directionality:

n/a

Interaction Info:

Mechanism of Interaction Sulfonylurea receptors; K-ATP channels opener

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions
NAMINIDIL KCNJ11

Interaction Score: 0.55

Interaction Types & Directionality:

n/a

Interaction Info:

Mechanism of Interaction Sulfonylurea receptors; K-ATP channels opener

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions
PINACIDIL KCNJ11

Interaction Score: 0.55

Interaction Types & Directionality:

n/a

Interaction Info:

Direct Interaction yes

Mechanism of Interaction Sulfonylurea receptor 2, Kir6.2 opener

PMIDs:
None found

Sources:
ChemblInteractions
PHENTOLAMINE KCNJ11

Interaction Score: 0.49

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
9326676

Sources:
NCI
NATEGLINIDE KCNJ11

Interaction Score: 0.44

Interaction Types & Directionality:

blocker (inhibitory)

Interaction Info:

Mechanism of Interaction Sulfonylurea receptor 1, Kir6.2 blocker

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions TEND
TOLBUTAMIDE KCNJ11

Interaction Score: 0.32

Interaction Types & Directionality:

blocker (inhibitory)

inhibitor (inhibitory)

Interaction Info:

Mechanism of Interaction Sulfonylurea receptor 1, Kir6.2 blocker

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions
TOLAZAMIDE KCNJ11

Interaction Score: 0.32

Interaction Types & Directionality:

blocker (inhibitory)

Interaction Info:

Mechanism of Interaction Sulfonylurea receptor 1, Kir6.2 blocker

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions
MINOXIDIL KCNJ11

Interaction Score: 0.22

Interaction Types & Directionality:

activator (activating)

Interaction Info:

Mechanism of Interaction Sulfonylurea receptor 2, Kir6.2 opener

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions
CHLORPROPAMIDE KCNJ11

Interaction Score: 0.2

Interaction Types & Directionality:

blocker (inhibitory)

Interaction Info:

Mechanism of Interaction Sulfonylurea receptor 1, Kir6.2 blocker

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions
EPIGALOCATECHIN GALLATE KCNJ11

Interaction Score: 0.17

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
17656102

Sources:
NCI
TACROLIMUS KCNJ11

Interaction Score: 0.13

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
22264780

Sources:
PharmGKB
METFORMIN KCNJ11

Interaction Score: 0.12

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
16595597

Sources:
PharmGKB
STREPTOZOCIN KCNJ11

Interaction Score: 0.1

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
11798815

Sources:
NCI

Ensembl: ENSG00000187486
- Version: 101_38
Alternate Names:

KCNJ11 Ensembl Gene Name

Gene Info:

Gene Biotype PROTEIN_CODING

Publications:
TEND: Q14654
- Version: 01-August-2011
Alternate Names:

ENSG00000187486 Ensembl Gene Id

Q14654 Uniprot Accession

KCNJ11 Gene Symbol

Gene Info:

Transmembrane Helix Count 2

Target Subclass Channels

Target Main Class Transporters

Publications:
RussLampel: ENSG00000187486
- Version: 26-July-2011
Alternate Names:

POTASSIUM INWARDLY-RECTIFYING CHANNEL, SUBFAMILY J, MEMBER 11 (KCNJ11), MRNA [SOURCE:REFSEQ_DNA;ACC:NM_000525] Description

NM_000525.3 Display Id

ENSG00000187486 Ensembl Gene Id

Gene Info:

Human Readable Name DRUGGABLE GENOME

Gene Categories:

DRUGGABLE GENOME

Publications:
BaderLabGenes: KCNJ11
- Version: February-2014
Alternate Names:

3767 Entrez Gene ID

Gene Info:

Initial Gene Query Kir6.2

Counted Citations from 1950-2000 1209

Gene Categories:

ION CHANNEL

Publications:
TdgClinicalTrial: Q14654
- Version: January-2014
Alternate Names:

KCNJ11 Gene Symbol

Gene Info:

Target Class Transporters

Target Subclass TC:1.A.2.1

Publications:

PharmGKB: KCNJ11

Version: 18-August-2020

Alternate Names:

PA217 PharmGKB ID

Gene Info:

Publications:

Klen J et al., 2014, CYP2C9, KCNJ11 and ABCC8 polymorphisms and the response to sulphonylurea treatment in type 2 diabetes patients., Eur J Clin Pharmacol

Sesti G et al., 2006, The E23K variant of KCNJ11 encoding the pancreatic beta-cell adenosine 5'-triphosphate-sensitive potassium channel subunit Kir6.2 is associated with an increased risk of secondary failure to sulfonylurea in patients with type 2 diabetes., J Clin Endocrinol Metab

Gloyn AL et al., 2001, Association studies of variants in promoter and coding regions of beta-cell ATP-sensitive K-channel genes SUR1 and Kir6.2 with Type 2 diabetes mellitus (UKPDS 53)., Diabet Med

NCI: KCNJ11

Version: 14-September-2017

Alternate Names:

Gene Info:

Publications:

Jin et al., 2007, Uncoupling by (--)-epigallocatechin-3-gallate of ATP-sensitive potassium channels from phosphatidylinositol polyphosphates and ATP., Pharmacol. Res.

Li et al., 2000, [Effects of glibenclamide on mRNA level of ATP-sensitive potassium channels of heart in normal and streptozotocin-induced diabetic rats]., Zhonghua Yi Xue Za Zhi

Proks et al., 1997, Phentolamine block of KATP channels is mediated by Kir6.2., Proc. Natl. Acad. Sci. U.S.A.

DTC: KCNJ11
- Version: 02-September-2020
Alternate Names:

Gene Info:

Publications:

Bian X et al., 2006, Synthesis and antihyperglycemic evaluation of various protoberberine derivatives., Bioorg Med Chem Lett
HingoraniCasas: ENSG00000187486
- Version: 31-May-2017
Alternate Names:

ENSG00000187486 Gene Symbol

KCNJ11 Ensembl Id

Gene Info:

Gene Categories:

DRUGGABLE GENOME

Publications:
ChemblInteractions: KCNJ11
- Version: chembl_23
Alternate Names:

KCNJ11 GENE_SYMBOL

ATP-sensitive inward rectifier potassium channel 11 UNIPROT

IKATP UNIPROT

Gene Info:

Publications:
Pharos: KCNJ11
- Version: 01-February-2022
Alternate Names:

ATP-sensitive inward rectifier potassium channel 11 Gene Name

Q14654 UniProt ID

Gene Info:

Gene Categories:

ION CHANNEL

Publications:

Mechanism of Interaction	Sulfonylurea receptor 1, Kir6.2 blocker
Direct Interaction	yes
Trial Name	glimepiride,Amaryl

Mechanism of Interaction	Potassium channel, inwardly rectifying, subfamily J, member 11 opener
Direct Interaction	yes

Novel drug target	Established target
Trial Name	-
Mechanism of Interaction	Sulfonylurea receptor 1, Kir6.2 blocker

Mechanism of Interaction	Sulfonylurea receptors; K-ATP channels opener
Direct Interaction	yes

Direct Interaction	yes
Mechanism of Interaction	Sulfonylurea receptor 2, Kir6.2 opener

ENSG00000187486	Ensembl Gene Id
Q14654	Uniprot Accession
KCNJ11	Gene Symbol

POTASSIUM INWARDLY-RECTIFYING CHANNEL, SUBFAMILY J, MEMBER 11 (KCNJ11), MRNA [SOURCE:REFSEQ_DNA;ACC:NM_000525]	Description
NM_000525.3	Display Id
ENSG00000187486	Ensembl Gene Id

KCNJ11	GENE_SYMBOL
ATP-sensitive inward rectifier potassium channel 11	UNIPROT
IKATP	UNIPROT

ATP-sensitive inward rectifier potassium channel 11	Gene Name
Q14654	UniProt ID

blocker (inhibitory)
inhibitor (inhibitory)

blocker (inhibitory)
inhibitor (inhibitory)

KCNJ11 Gene Record

KCNJ11 3767 Druggable Genome

Alternate Names:

Gene Info:

Gene Categories: Category Details

Publications:

Interaction Types & Directionality: blocker (inhibitory) inhibitor (inhibitory)

Interaction Info: Mechanism of Interaction Sulfonylurea receptor 1, Kir6.2 blocker Direct Interaction yes Trial Name glimepiride,Amaryl

PMIDs: 25115353 24442125 22385882 16595597 11318841 12086984 11325810 12703060

Sources: TdgClinicalTrial ChemblInteractions NCI TEND PharmGKB

Interaction Types & Directionality: inhibitor (inhibitory)

Interaction Info: Trial Name - Novel drug target Established target

PMIDs: 10754636 15852621 14739809

Sources: TdgClinicalTrial TEND

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: 16359864 25115353 24442125 22385882 16595597 11318841

Sources: DTC PharmGKB

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: 24442125 16595597 11318841 22385882 25115353

Sources: PharmGKB

Interaction Types & Directionality: inducer (activating)

Interaction Info: Trial Name Levosimendan Novel drug target Established target

PMIDs: 17452812

Sources: TdgClinicalTrial

Interaction Types & Directionality: blocker (inhibitory)

Interaction Info: Mechanism of Interaction Sulfonylurea receptor 1, Kir6.2 blocker Direct Interaction yes

PMIDs: 25115353 24442125 22385882 16595597 11318841

Sources: ChemblInteractions PharmGKB

Interaction Types & Directionality: inducer (activating)

Interaction Info: Mechanism of Interaction Potassium channel, inwardly rectifying, subfamily J, member 11 opener Direct Interaction yes

PMIDs: 12199344 16885550 15807877 11808879 12770942 10604939 10581306 10518593

Sources: ChemblInteractions PharmGKB

Interaction Types & Directionality: blocker (inhibitory) inhibitor (inhibitory)

Interaction Info: Novel drug target Established target Trial Name - Mechanism of Interaction Sulfonylurea receptor 1, Kir6.2 blocker

PMIDs: 25115353 24442125 22385882 16595597 11318841 9593694

Sources: TdgClinicalTrial ChemblInteractions TEND PharmGKB

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: 16359864

Sources: DTC

Interaction Types & Directionality: blocker (inhibitory)

Interaction Info: Mechanism of Interaction Sulfonylurea receptor 1, Kir6.2 blocker Direct Interaction yes

PMIDs: None found

Sources: ChemblInteractions

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: 11429398

Sources: NCI

Interaction Types & Directionality: blocker (inhibitory)

Interaction Info: Mechanism of Interaction Sulfonylurea receptor 1, Kir6.2 blocker Direct Interaction yes

PMIDs: None found

Sources: ChemblInteractions

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: None found

Sources: TEND

Interaction Types & Directionality: blocker (inhibitory)

Interaction Info: Mechanism of Interaction Sulfonylurea receptor 1, Kir6.2 blocker Direct Interaction yes

PMIDs: 20054294

Sources: ChemblInteractions TEND PharmGKB

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: 16359864

Sources: DTC

Interaction Types & Directionality: n/a

Interaction Info: Mechanism of Interaction Sulfonylurea receptors; K-ATP channels opener Direct Interaction yes

PMIDs: None found

Sources: ChemblInteractions

Interaction Types & Directionality: n/a

Interaction Info: Mechanism of Interaction Sulfonylurea receptors; K-ATP channels opener Direct Interaction yes

PMIDs: None found

Sources: ChemblInteractions

Interaction Types & Directionality: n/a

Interaction Info: Direct Interaction yes Mechanism of Interaction Sulfonylurea receptor 2, Kir6.2 opener

PMIDs: None found

Sources: ChemblInteractions

Interaction Types & Directionality: n/a

Interaction Info:

Interaction Types & Directionality:

blocker (inhibitory)

inhibitor (inhibitory)

Interaction Info:

Mechanism of Interaction Sulfonylurea receptor 1, Kir6.2 blocker

Direct Interaction yes

Trial Name glimepiride,Amaryl

PMIDs:
25115353 24442125 22385882 16595597 11318841 12086984 11325810 12703060

Sources:
TdgClinicalTrial ChemblInteractions NCI TEND PharmGKB

Interaction Types & Directionality:

inhibitor (inhibitory)

Interaction Info:

Trial Name -

Novel drug target Established target

PMIDs:
10754636 15852621 14739809

Sources:
TdgClinicalTrial TEND

Interaction Types & Directionality:

n/a

PMIDs:
16359864 25115353 24442125 22385882 16595597 11318841

Sources:
DTC PharmGKB

Interaction Types & Directionality:

n/a

PMIDs:
24442125 16595597 11318841 22385882 25115353

Sources:
PharmGKB

Interaction Types & Directionality:

inducer (activating)

Interaction Info:

Trial Name Levosimendan

Novel drug target Established target

PMIDs:
17452812

Sources:
TdgClinicalTrial

Interaction Types & Directionality:

blocker (inhibitory)

Interaction Info:

Mechanism of Interaction Sulfonylurea receptor 1, Kir6.2 blocker

Direct Interaction yes

PMIDs:
25115353 24442125 22385882 16595597 11318841

Sources:
ChemblInteractions PharmGKB

Interaction Types & Directionality:

inducer (activating)

Interaction Info:

Mechanism of Interaction Potassium channel, inwardly rectifying, subfamily J, member 11 opener

Direct Interaction yes

PMIDs:
12199344 16885550 15807877 11808879 12770942 10604939 10581306 10518593

Sources:
ChemblInteractions PharmGKB

Interaction Types & Directionality:

blocker (inhibitory)

inhibitor (inhibitory)

Interaction Info:

Novel drug target Established target

Trial Name -

Mechanism of Interaction Sulfonylurea receptor 1, Kir6.2 blocker

PMIDs:
25115353 24442125 22385882 16595597 11318841 9593694

Sources:
TdgClinicalTrial ChemblInteractions TEND PharmGKB

Interaction Types & Directionality:

n/a

PMIDs:
16359864

Sources:
DTC

Interaction Types & Directionality:

blocker (inhibitory)

Interaction Info:

Mechanism of Interaction Sulfonylurea receptor 1, Kir6.2 blocker

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions

Interaction Types & Directionality:

n/a

PMIDs:
11429398

Sources:
NCI

Interaction Types & Directionality:

blocker (inhibitory)

Interaction Info:

Mechanism of Interaction Sulfonylurea receptor 1, Kir6.2 blocker

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions

Interaction Types & Directionality:

n/a

PMIDs:
None found

Sources:
TEND

Interaction Types & Directionality:

blocker (inhibitory)

Interaction Info:

Mechanism of Interaction Sulfonylurea receptor 1, Kir6.2 blocker

Direct Interaction yes

PMIDs:
20054294

Sources:
ChemblInteractions TEND PharmGKB

Interaction Types & Directionality:

n/a

PMIDs:
16359864

Sources:
DTC

Interaction Types & Directionality:

n/a

Interaction Info:

Mechanism of Interaction Sulfonylurea receptors; K-ATP channels opener

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions

Interaction Types & Directionality:

n/a

Interaction Info:

Mechanism of Interaction Sulfonylurea receptors; K-ATP channels opener

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions

Interaction Types & Directionality:

n/a

Interaction Info:

Direct Interaction yes

Mechanism of Interaction Sulfonylurea receptor 2, Kir6.2 opener

PMIDs:
None found

Sources:
ChemblInteractions

Interaction Types & Directionality:

n/a

PMIDs:
9326676

Sources:
NCI

Interaction Types & Directionality:

blocker (inhibitory)

Interaction Info:

Mechanism of Interaction Sulfonylurea receptor 1, Kir6.2 blocker

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions TEND

Interaction Types & Directionality:

blocker (inhibitory)

inhibitor (inhibitory)

Interaction Info:

Mechanism of Interaction Sulfonylurea receptor 1, Kir6.2 blocker

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions

Interaction Types & Directionality:

blocker (inhibitory)

Interaction Info:

Mechanism of Interaction Sulfonylurea receptor 1, Kir6.2 blocker

Direct Interaction yes

PMIDs:
None found